N-acyl dopamines, including N-arachidonoyl dopamine, have been shown to reduce breast cancer cell migration and colony formation, reduce EMT markers, and enhance epithelial marker expression, by suppressing SREBP1. The gene discussed is SREBF1; the disease is breast carcinoma.